PHASE 2 CA GENETIC STUDIES OF ALZHEIMERS DISEASE

阿尔茨海默病（AD）是美国的主要健康问题之一， 随着老年人比例的增加，这一点越来越重要。 多 调查和家庭研究显示， 与主基因一致 本提案的总体目的是 确定与阿尔茨海默病（AD）有关的基因。 作为一个多- 由NIMH（精神病诊断中心）资助的中心合作研究 连锁研究），临床数据和DNA正在收集400个兄弟姐妹 多例家族性阿尔茨海默病（FAD） 这一努力 代表了正在进行的合作的延续，以测试 以下假设：1）一个主基因单独或相互作用 与其他基因引起FAD的常见形式：家庭将进行基因分型 对于高度多态性的标记，在整个过程中大约10cM的间隔 基因组 这项工作将由三个中心分担。 位点 报告的重要性，如与19 q在家庭中与老年人的联系， 发病年龄和发病年龄较早的家系中的14号染色体 将被优先考虑，以确定这些基因的重要性， 我们的家庭（82%）发病年龄大于65岁）。 此外，本发明还提供了一种方法， 将对家族进行淀粉样β蛋白已知突变的筛查， 21号染色体上的前体基因; 2）FAD是一种遗传异质性 无序：为了最大限度地提高我们检测连锁和异质性的能力， 连锁数据将使用标准似然技术进行分析， 年龄依赖性遗传率以及同胞对和受影响的谱系成员 不需要了解特定模式的方法 传承 将进行计算机模拟，以确定最佳的 分析战略，应采用; 3）一旦证据的联系是 获得了额外的高度多态性标记和候选基因， 染色体区域将被分型。 我们的实验室将开发更多的 根据需要在感兴趣的区域中使用高度多态性的标记。 三 各中心将在该项目中进行合作;数据将定期交换 类似的技术将用于基因分型和数据分析。

Alzheimer's disease (AD) is one of the major health problems in the US and of increasing importance as the proportion of elderly increases. Multiple survey and family studies have shown evidence for a genetic component consistent with a major gene. The overall purpose of this proposal is to identify genes involved in Alzheimer's disease (AD). As part of a multi- center cooperative study funded by NIMH (Diagnostic Centers for Psychiatric Linkage Studies), clinical data and DNA are being collected on 400 sibships with multiple cases of familial Alzheimer's disease (FAD). This effort represents a continuation of the ongoing collaboration to test the following hypotheses: 1) A major gene either singularly or interacting with other genes cause the common forms of FAD: Families will be genotyped for highly polymorphic markers at approximately 10cM intervals throughout the genome. This work will be divided between the 3 centers. Loci of reported significance such as the linkage to 19q in families with an older age-of-onset and chromosome 14 in families with an earlier age-of-onset will be prioritized in order to determine the importance of these genes in our families (82%) with age-of-onset greater than 65 years). In addition, families will be screened for known mutations in the amyloid beta protein precursor gene on chromosome 21; 2) FAD is a genetically heterogeneous disorder: To maximize our power to detect linkage and heterogeneity, linkage data will be analyzed using standard likelihood techniques with age-dependent penetrance as well as sib-pair and affected pedigree member approaches which do not require knowledge of a specific mode of inheritance. Computer simulations will be performed to determine the best analytic strategy that should be employed; 3) Once evidence for linkage is obtained, additional highly polymorphic markers and candidate genes in that chromosomal region will be typed. Our laboratories will develop additional highly polymorphic markers in regions of interest as required. Three centers will collaborate in this project; data will be routinely exchanged and, similar techniques will be used for genotyping and data analysis.